Prospective multicenter trial on the identification of novel biomarkers for Sunitinib therapy in the treatment of Japanese patients with metastatic renal cell carcinoma
Latest Information Update: 04 Nov 2017
At a glance
- Drugs Sunitinib (Primary)
- Indications Renal cell carcinoma
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- Sponsors Pfizer
- 21 Jan 2013 New trial record